87 related articles for article (PubMed ID: 7521895)
21. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
[TBL] [Abstract][Full Text] [Related]
22. Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study.
Park JB; Kim SJ; Oh HY; Han YS; Kim DJ; Park JW; Kwon CH; Joh JW; Lee SK
Transpl Int; 2006 Jun; 19(6):478-84. PubMed ID: 16771869
[TBL] [Abstract][Full Text] [Related]
23. [Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
Martínez Castelao A; Ramos R; Serón D; Gil-Vernet S; Fiol C; Gómez-Gerique N; Yzaguirre MT; Hurtado I; Sabaté I; Alsina J; Grinyó JM
Nefrologia; 2002; 22(4):364-9. PubMed ID: 12369128
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine.
Vanhaecke J; Van Cleemput J; Van Lierde J; Daenen W; De Geest H
Transplantation; 1994 Jul; 58(1):42-5. PubMed ID: 8036706
[TBL] [Abstract][Full Text] [Related]
25. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
Neal DA; Gimson AE; Gibbs P; Alexander GJ
Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
[TBL] [Abstract][Full Text] [Related]
26. Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study.
Ng YW; Liang S; Singh K
Contraception; 2009 Jan; 79(1):24-8. PubMed ID: 19041437
[TBL] [Abstract][Full Text] [Related]
27. Low-density lipoprotein oxidizability and the alteration of its fatty acid content in renal transplant recipients treated with cyclosporine/tacrolimus.
Bakar F; Keven K; Dogru B; Aktan F; Erturk S; Tuzuner A; Erbay B; Nebioglu S
Transplant Proc; 2009 Jun; 41(5):1630-3. PubMed ID: 19545695
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
Manzarbeitia C; Reich DJ; Rothstein KD; Braitman LE; Levin S; Munoz SJ
Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
[TBL] [Abstract][Full Text] [Related]
29. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Ott R; Bussenius-Kammerer M; Reck T; Koch CA; Kissler H; Hohenberger W; Müller V
Transpl Int; 2004 Jan; 17(1):39-43. PubMed ID: 14504723
[TBL] [Abstract][Full Text] [Related]
30. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
31. Short-term effects of renal transplantation on plasma lipids and lipoprotein lipase in children with congenital nephrosis.
Antikainen M; Holmberg C; Taskinen MR
Clin Nephrol; 1994 May; 41(5):284-9. PubMed ID: 8050208
[TBL] [Abstract][Full Text] [Related]
32. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
[TBL] [Abstract][Full Text] [Related]
33. Serum lipid concentrations correlate with the progression of chronic renal failure.
Yang WQ; Song NG; Ying SS; Liang HQ; Zhang YJ; Wei MJ; Wu KF
Clin Lab Sci; 1999; 12(2):104-8. PubMed ID: 10387487
[TBL] [Abstract][Full Text] [Related]
34. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
[TBL] [Abstract][Full Text] [Related]
36. Optimizing tacrolimus therapy in the maintenance of renal allografts: 12-month results.
Bolin P; Shihab FS; Mulloy L; Henning AK; Gao J; Bartucci M; Holman J; First MR;
Transplantation; 2008 Jul; 86(1):88-95. PubMed ID: 18622283
[TBL] [Abstract][Full Text] [Related]
37. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
38. Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation.
Siirtola A; Antikainen M; Ala-Houhala M; Solakivi T; Jokela H; Lehtimäki T; Holmberg C; Salo MK
J Heart Lung Transplant; 2004 Apr; 23(4):418-26. PubMed ID: 15063401
[TBL] [Abstract][Full Text] [Related]
39. The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
Hilbrands LB; Demacker PN; Hoitsma AJ; Stalenhoef AF; Koene RA
J Am Soc Nephrol; 1995 Jun; 5(12):2073-81. PubMed ID: 7579056
[TBL] [Abstract][Full Text] [Related]
40. Bile acid metabolism and biliary secretion in patients receiving orthotopic liver transplants: differing effects of cyclosporine and FK 506.
McCashland TM; Donovan JP; Amelsberg A; Rossi SS; Hofmann AF; Shaw BW; Quigley EM
Hepatology; 1994 Jun; 19(6):1381-9. PubMed ID: 7514561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]